Avidity Biosciences Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 01/29/2026 | 13.65 M | $984.52 M | 3.25% | 79.75% |
| BLACKROCK, INC. | 02/12/2026 | 12.85 M | $926.93 M | 39.64% | 75.09% |
| RA CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 8.64 M | $623.28 M | 0.00% | 50.49% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 6.94 M | $500.56 M | -52.22% | 40.55% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 6.04 M | $435.71 M | 100.00% | 35.30% |
| PENTWATER CAPITAL MANAGEMENT LP | 02/17/2026 | 6.03 M | $434.69 M | 100.00% | 35.21% |
| AVORO CAPITAL ADVISORS LLC | 03/16/2026 | 5.46 M | $393.47 M | -28.65% | 31.87% |
| HBK INVESTMENTS L P | 02/17/2026 | 4.37 M | $314.85 M | 100.00% | 25.50% |
| STATE STREET CORP | 02/13/2026 | 4.10 M | $295.58 M | -16.18% | 23.94% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 3.78 M | $272.42 M | 118.00% | 22.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 3.12 M | $225.14 M | 9.19% | 18.23% |
| NORGES BANK | 02/10/2026 | 3.05 M | $219.74 M | 100.00% | 17.80% |
| BELLEVUE GROUP AG | 02/17/2026 | 2.63 M | $189.77 M | 22.21% | 15.37% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 2.63 M | $189.77 M | 119.25% | 15.37% |
| GLAZER CAPITAL, LLC | 02/13/2026 | 2.47 M | $177.96 M | 100.00% | 14.42% |
| UBS GROUP AG | 01/29/2026 | 2.36 M | $170.00 M | 79.11% | 13.77% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 2.16 M | $155.60 M | 7,182.42% | 12.61% |
| TIG ADVISORS, LLC | 02/17/2026 | 1.80 M | $129.96 M | 100.00% | 10.53% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.59 M | $114.86 M | 76.98% | 9.30% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 1.43 M | $102.94 M | 628.11% | 8.34% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 1.18 M | $85.23 M | 5.15% | 6.90% |
| MAGNETAR FINANCIAL LLC | 02/17/2026 | 1.16 M | $83.57 M | 100.00% | 6.77% |
| FIL LTD | 02/17/2026 | 1.14 M | $82.52 M | 100.00% | 6.68% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 1.11 M | $79.76 M | 100.00% | 6.46% |
| MORGAN STANLEY | 02/13/2026 | 1.09 M | $78.80 M | 57.98% | 6.38% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 1.05 M | $75.55 M | 741.70% | 6.12% |
| KRYGER CAPITAL LTD | 02/17/2026 | 1.05 M | $75.40 M | 100.00% | 6.11% |
| NORTHERN TRUST CORP | 02/17/2026 | 1.02 M | $73.51 M | 4.52% | 5.95% |
| CASDIN CAPITAL, LLC | 02/17/2026 | 1.00 M | $72.13 M | -43.82% | 5.84% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/13/2026 | 983.13 K | $70.91 M | 57.30% | 5.74% |
| WESTCHESTER CAPITAL MANAGEMENT, LLC | 02/13/2026 | 962.66 K | $69.44 M | 100.00% | 5.62% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 02/17/2026 | 923.95 K | $66.64 M | 100.00% | 5.40% |
| TANG CAPITAL MANAGEMENT LLC | 02/17/2026 | 900.00 K | $64.92 M | 100.00% | 5.26% |
| MAN GROUP PLC | 02/17/2026 | 898.28 K | $64.79 M | 2,950.18% | 5.25% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 868.20 K | $62.62 M | 100.00% | 5.07% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 02/05/2026 | 867.53 K | $62.57 M | 100.00% | 5.07% |
| SOROS FUND MANAGEMENT LLC | 02/13/2026 | 840.98 K | $60.66 M | 100.00% | 4.91% |
| JPMORGAN CHASE & CO | 02/11/2026 | 820.99 K | $59.22 M | -8.73% | 4.80% |
| SOFINNOVA INVESTMENTS, INC. | 02/13/2026 | 745.12 K | $53.75 M | -14.93% | 4.35% |
| TUDOR INVESTMENT CORP ET AL | 02/17/2026 | 733.01 K | $52.87 M | 100.00% | 4.28% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 723.12 K | $52.16 M | -92.82% | 4.23% |
| SLOTNIK CAPITAL, LLC | 02/13/2026 | 715.00 K | $51.57 M | 100.00% | 4.18% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 706.67 K | $50.97 M | -59.04% | 4.13% |
| VERITION FUND MANAGEMENT LLC | 02/13/2026 | 680.72 K | $49.10 M | 1,800.02% | 3.98% |
| WOODLINE PARTNERS LP | 02/17/2026 | 671.62 K | $48.44 M | 107.44% | 3.92% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/17/2026 | 642.22 K | $46.32 M | 100.00% | 3.75% |
| NEUBERGER BERMAN GROUP LLC | 02/13/2026 | 622.44 K | $44.90 M | 285.57% | 3.64% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 619.53 K | $44.69 M | -62.20% | 3.62% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 610.55 K | $44.04 M | 2,137.17% | 3.57% |
| LMR PARTNERS LLP | 02/17/2026 | 598.53 K | $43.17 M | 100.00% | 3.50% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Avidity Biosciences Inc institutional Ownership - FAQ's
During the previous two years, 427 institutional investors and hedge funds held shares of Avidity Biosciences Inc. The most heavily invested institutionals were:
UBS Group AG: 49,814
Bank of New York Mellon Corp: 43,697
Nuveen, LLC: 25,307
Cannon Global Investment Management, LLC: 25,087
CREDIT INDUSTRIEL ET COMMERCIAL: 23,000
Fractal Investments LLC: 20,000
821.61% of Avidity Biosciences Inc stock is owned by institutional investors.
Institutional investors have bought a total of 148.03 M shares in the last 24 months. This purchase volume represents approximately $2.19 B in transactions.